Quantum Capital Management (California)’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Quantum Capital Management (California)’s Portfolio CNCR Stock Details CNCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$8K	Hold	300	–	–	0.01%	212
2020 Q2	$8K	Hold	300	–	–	﹤0.01%	285
2020 Q1	$6K	Hold	300	–	–	﹤0.01%	294
2019 Q4	$7K	Hold	300	–	–	﹤0.01%	305
2019 Q3	$6K	Buy	+300	New	+$6.09K	﹤0.01%	311

Other funds holding CNCR

BCWM LLC Overland Park, Kansas $353M AUM 20.1% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

LWPC

Legacy Wealth Partners (California) Calabasas, California $180M AUM 48.85% 1-Year Est. Return

Quantum Capital Management (California)'s CNCR Position: Q3 2020 in Review

Quantum Capital Management (California) held its ETF Series Solutions Trust Range Cancer Therapeutics ETF (CNCR) position steady in Q3 2020 at 300 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #212.

Quantum Capital Management (California) first reported a position in CNCR in Q3 2019 and has held it in 5 quarters since. 21 funds tracked by Wall St. Rank hold CNCR as of Q3 2020.

Quantum Capital Management (California) held 300 shares of ETF Series Solutions Trust Range Cancer Therapeutics ETF worth $8K as of Q3 2020.
Quantum Capital Management (California) left its ETF Series Solutions Trust Range Cancer Therapeutics ETF share count unchanged in Q3 2020.
ETF Series Solutions Trust Range Cancer Therapeutics ETF made up 0.01% of Quantum Capital Management (California)'s portfolio in Q3 2020, its #212 holding.
Quantum Capital Management (California) first reported a position in ETF Series Solutions Trust Range Cancer Therapeutics ETF in Q3 2019 and has held it in 5 quarters since.
21 funds tracked by Wall St. Rank held ETF Series Solutions Trust Range Cancer Therapeutics ETF as of Q3 2020.

Based on Quantum Capital Management (California)'s 13F filing for Q3 2020, filed 16 Nov 2020.